TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04714658

Intervention type: OTHER
Group type: OTHER
Intervention: Therapeutic Education
Description: Each patient will participate in 1 to 3 PTE sessions.~1. st group collective workshop : allow the patient to better understand autoimmune~2. nd workshop : fatigue and techniques that enable its best management.~3. rd workshop : improving the management of the emotions generated by myasthenia. It allows patients to express their experiences of the disease in front of a group, to talk about their difficulties in their relationships and mobilize their resources to promote exchanges.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Education
Description: Each patient will participate in 1 to 3 PTE sessions.~1. st group collective workshop : allow the patient to better understand autoimmune~2. nd workshop : fatigue and techniques that enable its best management.~3. rd workshop : improving the management of the emotions generated by myasthenia. It allows patients to express their experiences of the disease in front of a group, to talk about their difficulties in their relationships and mobilize their resources to promote exchanges.
Study: NCT05456074

Intervention type: OTHER
Intervention: Data collection
Description: Retrospective data collection

Intervention type: OTHER
Intervention: Data collection
Description: Retrospective data collection
Study: NCT06357338

Intervention type: OTHER
Intervention: no intervention
Description: No intervention

Intervention type: OTHER
Intervention: no intervention
Description: No intervention
Study: NCT06496061

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Description: Norepinephrine infusion with 0.05 mg/kg/h

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine
Description: Norepinephrine infusion with 0.05 mg/kg/h

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leg wrapping
Description: Elastic leg wrapping
Study: NCT05227625

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: body dissatisfaction management group
Description: Our group is composed of 10 weekly session of 2 hours led by a psychologist trained in the management of ED and ACT therapy.~Each group will be composed of 5 to 10 people. First of all, the group will lead the participants to better know and understand the impact of BD on the symptomatology of ED by teaching current scientific knowledge on the subject. In a second step, the group will guide the patients in the acquisition of psychological skills to deal with events related to BD and to engage in actions towards the values that give meaning to their existence.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation Group
Description: Participants will be included in a standardized relaxation program consisting of a weekly 2 hour session for 10 weeks. The group will be led by a psychologist trained in relaxation and in particular in abdominal and muscular relaxation techniques. Each group will be composed of 5 to 10 people. Initially, the therapy will lead the participants to recognize the signs of anxiety and to understand the physiological mechanisms involved. Classic techniques of anxiety management will then be introduced (cardiac coherence, abdominal and muscular relaxation, Jacobson technique, Schultz autogenic training). These techniques will be tested in session. Participants will be encouraged to practice these techniques at home.
Study: NCT05229757

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy and rehabilitation treatment in a special education and rehabilitation center.
Description: Routine physiotherapy and rehabilitation practice was performed 2 days a week for 8 weeks in the special education and rehabilitation center.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Family-based home exercise.
Description: Home exercise was applied by the families every day of the week for 8 weeks.
Study: NCT05796310

Intervention type: DIAGNOSTIC_TEST
Intervention: Salivary collection
Description: Collection of saliva via swab for miRNA processing

Intervention type: DIAGNOSTIC_TEST
Intervention: Salivary collection
Description: Collection of saliva via swab for miRNA processing

Intervention type: DIAGNOSTIC_TEST
Intervention: Salivary collection
Description: Collection of saliva via swab for miRNA processing

Intervention type: DIAGNOSTIC_TEST
Intervention: eye-tracking recorder
Description: Administration of eye-tracking session recording Saccadic Eye Movements, fixation duration and pupillary response.

Intervention type: DIAGNOSTIC_TEST
Intervention: eye-tracking recorder
Description: Administration of eye-tracking session recording Saccadic Eye Movements, fixation duration and pupillary response.

Intervention type: DIAGNOSTIC_TEST
Intervention: eye-tracking recorder
Description: Administration of eye-tracking session recording Saccadic Eye Movements, fixation duration and pupillary response.

Intervention type: DIAGNOSTIC_TEST
Intervention: neuropsychological assessment
Description: Administration of neuropsychological tests and collected patient medical history
Study: NCT05182632

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group pelvic floor telerehabilitation
Description: Multimodal group physiotherapy: 12 weeks of weekly group physiotherapy treatments including education and pelvic floor muscle exercises delivered online + home exercise program
Study: NCT04888910

Intervention type: OTHER
Intervention: observational
Description: observation of biomarkers in different asthma groups

Intervention type: OTHER
Intervention: observational
Description: observation of biomarkers in different asthma groups
Study: NCT06336863

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Allosure and TruGraf
Description: Precision medicine will be employed to withdraw immunosuppression in kidney transplant recipients.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Allosure and TruGraf
Description: Precision medicine will be employed to withdraw immunosuppression in kidney transplant recipients.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Immunosuppression Taper
Description: An immunosuppression taper will be employed over a 12-month period for those that are deemed immune quiescent.
Study: NCT06096103

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Route: Oral Dosage: 500mg Dosage Form: Capsule Frequency: Once a Day Duration: 60 Days Mode of Usage: Take the capsule once a day with food

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Botanical Extract Standardized for Iron + Vitamin C
Description: Route: Oral Dosage: 500mg Dosage Form: Capsule Frequency: Once a Day Duration: 60 Days Mode of Usage: Take the capsule once a day with food

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Botanical Extract Standardised for Iron
Description: Route: Oral Dosage: 500mg Dosage Form: Capsule Frequency: Once a Day Duration: 60 Days Mode of Usage: Take the capsule once a day with food
Study: NCT05428722

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: deep breathing exercises with a incentive spirometer
Description: Deep breathing exercise will be explained to the patients with an incentive spirometer (IS), it will be demonstrated in practice and it will be applied from the first day of hospitalization in addition to routine treatment and care. The patient will be informed about whether they are doing it right and their questions will be answered. It will be ensured that the patients start after breakfast in the morning and make 5-10 inspirations, hold her/his breath for 3 seconds and 5-10 expirations per hour with IS until they fall asleep. The research nurse will warn the patients that they should do the exercise every hour, and the alarms of the patients' mobile phones will be set to ring every hour to be a warning. The start and end time of the exercise will be decided together with the patient, and usually the time of waking and going to bed will be taken into account.
Study: NCT05912322

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Black chokeberry juice
Description: 100ml black chokeberry juice/day
Study: NCT05462561

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic Vascularized Composite Bladder Allograft Transplantation
Description: Undergo robotic VCBA transplantation.
Study: NCT04574193

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital therapeutic for substance use disorders
Description: The Continuing Care application (app) is a HIPAA-compliant, mobile-friendly, software program designed to meet the recovery and personal support needs of probationers and parolees with SUDs who are at elevated risk of relapse, re-arrest, and incarceration.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment As Usual
Description: 12-weeks of weekly group cognitive behavioral therapy
Study: NCT05258942

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.

Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.
Study: NCT05412407

Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaire
Description: description of analgesic self-medication in the context of acute pain using a questionnaire evaluating the drug taken, the dosage, the duration of treatment, the type of pain, its intensity, the origin of the drug, the source of information consulted and the factors that prompted the patient to self-medicate
Study: NCT04595981

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Subjects will be admitted to the UAB Heart and Vascular Center, pre-medicated with 24 mg Ondansetron IV, 500 mg Prednisolone IV and 1.5 L NaCl with 20 meq KCl IV. The chemo-embolic agent is prepared in the HVC pharmacy by reconstituting 300 mg lyophilized Cisplatin in 60 mL 0.9% NaCl. Subjects are placed under anesthesia in the angiography suite. The access site is prepped and draped in sterile fashion then the femoral artery is catheterized using a 5-French catheter containing a coaxial microcatheter. After superselective visualization of the tumor-feeding vessel, a microcatheter is advanced into the target vessel and infused with 150 mg m2 cisplatin in 45-60 mL NaCl over 30-60 seconds. 10 seconds after the infusion starts, 9 gm sodium thiosulphate is administered IV to neutralize systemic Cisplatin. A post-infusion angiogram is then performed to assess the adequacy of embolization. The catheter is removed and the arteriotomy site closed with a subcutaneous suture.
Study: NCT05003648

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pramipexole
Description: Participants will be started on 0.125 mg pramipexole for the first week. If this dose is well tolerated but not effective, the dose can be increased to 0.25 mg for the following week. If this dose is well tolerated but not effective, the dose can be further increased to 0.5 mg for the remainder of the 2-month period.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study: NCT05634109

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Transfusion of blood products
Description: The intervention will be either a) administration of 6 units of whole blood or b) administration of blood component therapy in the proportion of 6:6:6 units of red blood cells, plasma, and platelets.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Transfusion of blood products
Description: The intervention will be either a) administration of 6 units of whole blood or b) administration of blood component therapy in the proportion of 6:6:6 units of red blood cells, plasma, and platelets.
Study: NCT04852003

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR0410 Injection
Description: SHR0410 Injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for SHR0410 Injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: Morphine
Study: NCT04862078

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Shared decision making
Description: Shared decision making and decide surveillance strategy between standard follow-up according to the institutional practice and decide what to do advanced imagings for surveillance and guideline-based surveillance

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Usual care
Description: standard follow-up according to the institutional practice
Study: NCT06458439

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epcoritamab
Description: * C1D1: fixed priming dose of 0.16 mg subcutaneous injection~* C1D8: fixed intermediate dose of 0.8 mg subcutaneous injection~* C1D15 onward: fixed full dose of 48 mg subcutaneous injection
Study: NCT05718778

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piamprimab (AK105)
Description: Piamprilizumab (AK105) combined with radiotherapy for neoadjuvant treatment of soft tissue sarcoma
Study: NCT04986332

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity program
Description: 24-weeks moderate-intensity physical activity program

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity program
Description: 24-weeks moderate-intensity physical activity program

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity program
Description: 24-weeks moderate-intensity physical activity program

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Global therapeutic remodeling
Description: Re-assessing and therapeutic optimization of the whole burden of chronic pathologic conditions

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Global therapeutic remodeling
Description: Re-assessing and therapeutic optimization of the whole burden of chronic pathologic conditions

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Global therapeutic remodeling
Description: Re-assessing and therapeutic optimization of the whole burden of chronic pathologic conditions
Study: NCT05806710

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: GourMed© meal
Description: patients receive GourMed© meal as lunch for 7 consecutive days
Study: NCT05886543

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional chest physical therapy
Description: Conventional chest physical therapy: The patients performed four series of five breath with 3 seconds of sustained breathing interspersed with periods of quite breathing followed by two or three coughs or huffs (with wound support by a pillow or his/her hands), twice a day in the first two postburned days and once a day from the third to the tenth days.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional chest physical therapy
Description: Conventional chest physical therapy: The patients performed four series of five breath with 3 seconds of sustained breathing interspersed with periods of quite breathing followed by two or three coughs or huffs (with wound support by a pillow or his/her hands), twice a day in the first two postburned days and once a day from the third to the tenth days.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates exercise
Description: The Pilates technique, which stretched laterally and to the back, stressed costal breathing, in which the ribs climb and drop throughout the ventilatory stream. The transverse muscle had to work harder to avoid abdominal distension, provide more support to the diaphragm to promote lower rib movement, and provide more diaphragmatic excursion, During the expiratory phase, the transversus abdominis, the multifidus and the pelvic floor musculature were contracted.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates exercise
Description: The Pilates technique, which stretched laterally and to the back, stressed costal breathing, in which the ribs climb and drop throughout the ventilatory stream. The transverse muscle had to work harder to avoid abdominal distension, provide more support to the diaphragm to promote lower rib movement, and provide more diaphragmatic excursion, During the expiratory phase, the transversus abdominis, the multifidus and the pelvic floor musculature were contracted.
Study: NCT06030505

Intervention type: OTHER
Intervention: No intervention required by the protocol
Description: No visits or samples will be taken specifically for this study. This research involves only prospective or retrospective data collection in relation to the usual hospital management of the child included. Similarly, patient follow-up will be strictly within the framework of their usual hospital care in relation to their pathology.

Intervention type: OTHER
Intervention: No intervention required by the protocol
Description: No visits or samples will be taken specifically for this study. This research involves only prospective or retrospective data collection in relation to the usual hospital management of the child included. Similarly, patient follow-up will be strictly within the framework of their usual hospital care in relation to their pathology.
Study: NCT05676866

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Targeted axillary lymph node dissection
Description: Targeted axillary lymph node dissection is done by marking suspicious node with metallic clip prior to neo adjuvant therapy ,then neo adjuvant therapy is given and after complete axillary response (proved by radiological and clinical examination) , targeted axillary lymph node dissection of clipped node is done along with sentinel lymph node dissection
Study: NCT05822232

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FreeStyle Libre 2 CGM
Description: FreeStyle Libre 2 CGM is FDA-approved and will be used according to FDA-approved labeling

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FreeStyle Libre Pro blinded CGM
Description: FreeStyle Libre Pro blinded CGM is FDA-approved and will be used according to FDA-approved labeling

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FreeStyle Libre Pro blinded CGM
Description: FreeStyle Libre Pro blinded CGM is FDA-approved and will be used according to FDA-approved labeling

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FreeStyle Precision Neo blood glucose meter
Description: FreeStyle Precision Neo blood glucose meter is FDA-approved and will be used according to FDA-approved labeling
Study: NCT06346210

Intervention type: PROCEDURE
Intervention: Tracheostomy
Description: Surgery for tracheostomy
Study: NCT06387147

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gentamicin
Description: Gentamicin 80 mg 3 times per day during 14 days oral route or nasogastric tube or jejunostomy tube (in the case of an ostomy)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Gentamicin placebo (2ml sodium chloride diluted 1/10 in a syringe of 20mL Metronidazole placebo in tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: Métronidazole 500mg 3 times per day during 14 days oral route or nasogastric tube or jejunostomy tube (in the case of an ostomy)
Study: NCT06121037

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: proximal ultrasound-guided GON radiofrequency ablation
Description: proximal GON radiofrequency

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: distal ultrasound-guided GON radiofrequency ablation
Description: distal GON radiofrequency
Study: NCT05190510

Intervention type: OTHER
Intervention: Data collection
Description: Collection of data from preoperative imaging examinations (routine examination prescribed before the operation)

Intervention type: PROCEDURE
Intervention: collection of the carotid plaque (surgical specimen)
Description: collection of the carotid plaque

Intervention type: OTHER
Intervention: anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens
Description: anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens
Study: NCT06268522

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement: (MORE) group
Description: Mindfulness-Oriented Recovery Enhancement (MORE) is a novel social work intervention and mental training program that unites complementary aspects of mindfulness training.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psychoeducation
Description: Education on the neurobiology of pain, healthy eating, diet, sleep and stress
Study: NCT04018625

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMART Mom
Description: SMART Pregnancy is an 8-session online stress management program offered in a group format. SMART Pregnancy is an adaptation of the Stress Management and Resiliency Training Program (Park et al., 2012).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mama Support
Description: Participants will be enrolled in an 8-week time and attention matched, process-based support group.